A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

University of Chicago researchers developed an mRNA nanoparticle system that triggers cells to produce PD-L1 protein, potentially delaying type 1 diabetes progression in animal models.

A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...

Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.

A new method can produce specially designed proteins that can arm T cells to attack cancer cells. Precision personalized cancer treatment on a larger scale has come a step closer after researchers ...

Researchers at the University of Sharjah are exploring a promising approach that could enhance the immune system’s ability to fight cancer, potentially paving the way for new treatments. In a recent ...

Though CAR T cells have been effective against certain blood cancers, they have not been for solid tumors. Now, a new form of highly sensitive CAR T cells aims to overcome one of the biggest barriers ...

Etelka is a post-doctoral research fellow exploring aerosol science with biology and engineering. Etelka is a post-doctoral research fellow exploring aerosol science with biology and engineering.View ...